RMC-4550 | Interleukin Related interleukin-related.com

Product Name :
RMC-4550

Search keywords :
RMC-4550

drugId :
null

Target Vo:
Src homology phosphotyrosyl phosphatase 2

Target Vo Short Name :
SHP2

Moa_Name:
Src homology phosphotyrosyl phosphatase 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Revolution Medicines Inc

Active Company_Name :
Revolution Medicines Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOD2 Antibody (YA071)
NFAT2 Antibody
PPP4C Antibody (YA687): PPP4C Antibody (YA687) is a non-conjugated and Mouse origined monoclonal antibody about 35 kDa, targeting to PPP4C (2F11). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts